Cosmetics & Personal Care | Q4 2020
Regulatory news - Commercial news
Amending Annex II, III and VI of Cosmetics Regulation
On 13 November 2020, the European Commission published the following amendments related to cosmetics products.
Please find below a table summarising the most recent publications (non-exhaustive) by European Commission:
|
Date |
Title |
|
14/12/2020 |
Chemicals: EU takes action for safer tattooing inks and permanent make-up |
|
16/11/2020 |
Borderline working document on leave on hand gels |
|
12/11/2020 |
Draft Commission Regulation amending and correcting Annex II and amending Annexes III, IV and VI to Regulation (EC) No 1223/2009 of the European Parliament and of the Council on cosmetic products.
|
Recent SCCS publications on Cosmetics
Below are some recent publications by the Scientific Committee on Consumer Safety (SCCS), covering preliminary opinions, requests and mandates about cosmetics ingredients:
- SCCS - Preliminary Opinion open for comments on Hydroxyapatite (nano) - deadline: 4 January 2021
- SCCS - Preliminary Opinion open for comments on Copper (nano) and Colloidal Copper (nano) - deadline: 4 January 2021
- SCCS - Preliminary Opinion open for comments on Homosalate (deadline: 4 January 2021)
- SCCS - Preliminary Opinion open for comments on Propylparaben (deadline: 4 January 2021)
- SCCS - Request for a scientific Opinion on UV-filter HAA299 (nano)
- SCCS - Request for an Addendum to the scientific opinion SCCS/1613/19 on the safety of aluminium in cosmetic products - Submission II
- SCCS - Final Opinion on Methyl-N-methylanthranilate (MNM).
- SCCS - Preliminary Opinion open for comments on Resorcinol - deadline: 22 December 2020.
- SCCS - Final Opinion on Titanium dioxide (TiO2) used in cosmetic products that lead to exposure by inhalation
- SCCS - Scientific Advice open for comments on the safety of nanomaterials in cosmetics (deadline: 2 November 2020)
- SCCS - Request for a scientific Opinion on Methyl salicylate used in cosmetic products
- SCCS - Preliminary Opinion open for comments on Benzophenone-3
- SCCS - Preliminary Opinion open for comments on "Addendum to the scientific opinion SCCS/1613/19 on the safety of aluminium in cosmetic products (lipstick) - Submission II
Brexit transition: new rules for 2021
On 20 November 2020, the UK government published Guidance about cosmetic products.
Eurofins CRL, Inc. Mask Resistance Testing For Colored Facial Cosmetics
Over the past several months, face masks have become a required part of our everyday lives. While face masks are important in preventing the spread of COVID-19, they often impact our facial skin and the products we apply every day. Consumers now struggle with the longevity of their facial foundation, powder, and blush. Eurofins CRL has extensive experience with transfer resistance testing for facial color cosmetics. They have developed protocols to apply transfer resistance testing methodologies to evaluate the application of foundation, powder, or blush, coupled with short or long term wear of face masks, to determine a product’s facial retention ability and classification as “Mask Resistant.” This claim will resonate with consumers as they search for products that have minimal color transfer properties.
Contact us for more information! >>
Protect your skin from face mask skin problems
New test protocols and solutions designed for daily mask wearing concerns
In order to assess the protective, soothing, anti-friction and sebum-regulating effects of facial care against prolonged mask wear, Eurofins Dermscan offers a set of protocols specifically adapted to this constraint. Our teams also offer tests to demonstrate the long wear and absence of transfer of your makeup products Standard or custom-made protocols, Eurofins Dermscan has a solution for your claims « Mask-friendly », « Mask-wear », « Mask-resistant », « Mask-proof ».
Eurofins Evic France New Offer - Launch of In-Vitro PhotoEpiskin Test Method
Test method well adapted for determining the cytotoxic potential of cosmetic finished products
The test method aims at determining the cytotoxic potential of a photoreactive test element after exposure to light, using an alternative method to animal experimentation with the use of a reconstructed skin model. The test protocol in place is the closest to the one currently under review by the OCDE for regulatory validation and is performed under GLP. It is well adapted for products that can't be tested against 432 such as finished products, lipophilic products or pigments.
Contact us for more information! >>
Eurofins Cosmetics & Personal Care Spain New Offer - Evaluation of the Antiplaque Effect
Clinical study under dentist control
The O'Leary index measures the amount of bacterial dental plaque on teeth. The antiplaque effect of the product is evaluated by comparing the number of dental surfaces stained with substances that reveal bacterial plaque, on the total of dental surfaces, before and after treatment. For more information on this and all of our clinical studies under dentist control please contact us for more information.
Contact us for more information! >>
Eurofins Cosmetics & Personal Care Spain New Offer - Evaluation of the Product Efficacy Against Bad Breath
Clinical study under dentist control
The efficacy against bad breath of a product is evaluated by portable gas chromatography with OralChromaTM chromatograph. This chromatograph is equipped with a highly sensitive Indium Oxide (In2O3) detector, capable of identifying 3 volatile sulfide compounds (CVS) associated with Intra-Oral or Extra-Oral bad breath, that is, bad breath originating within or outside the oral cavity, before and after treatment.
These compounds are:
- Hydrogen sulfide, (H2S)
- Methyl mercaptan or MM, (CH3SH)
- Dimethylsulfide or DMS, (CH3SCH3)
The first two compounds are associated with Intra-Oral bad breath, whose origin is bacterial plaque and gingivitis, while the third compound is associated with Extra-Oral bad breath originating in the respiratory and digestive system. The equipment measures the 3 gases independently and, according to the ppb obtained, it is diagnosed if there is bad breath or not and its severity leve.
Contact us for more information! >>
Announcement: Derma Tronnier joins Eurofins
As part of our strategy to strengthen capabilities in Cosmetics & Personal Care, and to expand our footprint in Germany, Eurofins announced on 19 January 2021 that it has closed the acquisition of Derma Tronnier.
The acquisition of this German Contract Research Organization will complement Eurofins Cosmetics & Personal Care’s 15 state-of-the-art clinical laboratories all over the world, in order to support our customers by developing high-performing and safe products.
Eurofins CRL Offers Virtual Client GCP (Good Clinical Practice) Training
Good Clinical Practice (GCP) is an international standard that details the proper conduct of a clinical study, including everything prior to study start, during study conduct, and post study completion.
The goal of this training is to provide professionals in the cosmetic industry with a solid background in Good Clinical Practice (GCP) Guidelines. General topics are discussed, including relevant historical events that have led to the creation of the GCP guidelines, national legislation, along with other international standards.
The training is broken into two parts; information in the GCPs that relates to pre-study conduct and events that take place during a study and after a study is completed. The first part of the training includes, but is not limited to, study conduct responsibilities being assigned to relevant parties, proper recruiting methods, protocol generation and approval, and ethics committee involvement.
The second part of the training will go over any items that take place during a study or after a study is completed. This includes, but is not limited to, protocol adherence, proper documentation of protocol changes, the informed consent process, subject confidentiality, safety reporting, archival or documentation of test material upon study completion, and reporting study results.
Upon conclusion of this one day course, a quiz will be distributed to all participants. All quizzes will be graded and a discussion will be held to go over the correct answers and any other questions participants may have. Once both sections and quizzes are finished, all participants will be provided with a certificate of completion.
This training will allow both the laboratories conducting clinical research and the companies sponsoring the testing to become more aligned with terminology and expectations when it comes to all processes before, during, and after clinical study conduct. This will further improve vendor and client relationships, and improve the quality of clinical testing being performed.
If you are interested in scheduling a Virtual GCP training course, please contact us.
